Retraction notice to "Differential impact of diabetes and hypertension in the brain: Adverse effects in grey matter" [Neurobiol. Dis., 44 (2011) 161-173, http://dx.doi.org/10.1016/j.nbd.2011.06.005];Differential impact of diabetes and hypertension in the brain: Adverse effects in grey matter

Neurobiology of Disease

Volumn 44, Issue 2, 2011, Pages 161-173

  DeVisser, Adriena ^a   Yang, Christina ^a   Herring, Amanda ^a   Martinez, Jose A ^a   Rosales Hernandez, Alma ^a   Poliakov, Ilia ^a   Ayer, Amit ^a   Garven, Alexandra ^a   Zaver, Shaila ^a   Rincon, Natalia ^a   Xu, Kevin ^a   Tuor, Ursula I ^a,b   Schmidt, Ann Marie ^c   Toth, Cory ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cerebral atrophy; Diabetes; Hypertension; Insulin receptor; Vascular disease; White matter abnormalities

Indexed keywords

INSULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN PERFUSION; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GRAY MATTER; HIPPOCAMPUS; HISTOLOGY; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

EID: 80052288248     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.05.006     Document Type: Erratum

References (47)

1. Akisaki T., Sakurai T., Takata T., Umegaki H., Araki A., Mizuno S., Tanaka S., Ohashi Y., Iguchi A., Yokono K., Ito H. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese Elderly Diabetes Intervention Trial (J-EDIT). Diabetes Metab. Res. Rev. 2006, 22:376-384.
2. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996, 45(9):1259-1266. (Sep).
3. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008, 7:184-190.
4. Breteler M.M. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging 2000, 21:153-160.
5. Chiu S.L., Chen C.M., Cline H.T. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 2008, 58(5):708-719.
6. Cui Q.L., Almazan G. IGF-I-induced oligodendrocyte progenitor proliferation requires PI3K/Akt, MEK/ERK, and Src-like tyrosine kinases. J. Neurochem. 2007, 100:1480-1493.
7. Dahlquist G., Kallen B. School performance in children with Type 1 diabetes-a population-based register study. Diabetologia 2007, 50:957-964.
8. De Felice F.G., Vieira M.N., Bomfim T.R., Decker H., Velasco P.T., Lambert M.P., Viola K.L., Zhao W.Q., Ferreira S.T., Klein W.L. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1971-1976.
9. de Groot J.C., de Leeuw F.E., Oudkerk M., van G.J., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann. Neurol. 2000, 47:145-151.
10. Dhamoon M.S., Noble J.M., Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2009, 72(3):292-293.
11. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., Burwood A., Weinger K., Bayless M., Dahms W., Harth J. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 2007, 356:1842-1852. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.
12. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997, 75:661-665.
13. Francis G.J., Martinez J.A., Liu W.Q., Xu K., Ayer A., Fine J., Tuor U.I., Glazner G., Hanson L.R., Frey W.F., Toth C. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine Type 1 diabetic encephalopathy. Brain 2008, 131:3311-3334.
14. Francis G., Martinez J., Liu W., Nguyen T., Ayer A., Fine J., Zochodne D., Hanson L.R., Frey W.H., Toth C. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes 2009, 58:934-945.
15. Hassing L.B., Hofer S.M., Nilsson S.E., Berg S., Pedersen N.L., McClearn G., Johansson B. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004, 33:355-361.
16. Huang C., Thirone A.C., Huang X., Klip A. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. J. Biol. Chem. 2005, 280:19426-19435.
17. Huang T.J., Verkhratsky A., Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol. Cell. Neurosci. 2005, 28:42-54.
18. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., Burwood A., Weinger K., Bayless M., Dahms W., Harth J. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 2007, 356:1842-1852.
19. Kamal A., Biessels G.J., Gispen W.H., Ramakers G.M. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats. Brain Res. 2006, 1073-1074:276-280.
20. Kim-Mitsuyama S., Yamamoto E., Tanaka T., Zhan Y., Izumi Y., Izumiya Y., Ioroi T., Wanibuchi H., Iwao H. Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats. Stroke 2005, 36:1083-1088.
21. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss R.A., Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 1997, 272:17810-17814.
22. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995, 274:1846-1851.
23. Lee C.C., Huang C.C., Wu M.Y., Hsu K.S. Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J. Biol. Chem. 2005, 280:18543-18550.
24. Leinninger G.M., Backus C., Uhler M.D., Lentz S.I., Feldman E.L. Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J. 2004, 18:1544-1546.
25. Li Z.G., Zhang W., Sima A.A. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 2007, 56:1817-1824.
26. Lipscombe L.L., Hux J.E. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
27. Meneses A., Castillo C., Ibarra M., Hong E. Effects of aging and hypertension on learning, memory, and activity in rats. Physiol. Behav. 1996, 60:341-345.
28. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
29. Ohinmaa A., Jacobs P., Simpson S., Johnson J.A. The projection of prevalence and cost of diabetes in Canada: 2000-2016. Can. J. Diabetes 2004, 28:116-123.
30. Peltier J., O'Neill A., Schaffer D.V. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev. Neurobiol. 2007, 67:1348-1361.
31. Qiao M., Latta P., Foniok T., Buist R., Meng S., Tomanek B., Tuor U.I. Cerebral blood flow response to a hypoxic-ischemic insult differs in neonatal and juvenile rats. MAGMA 2004, 17:117-124.
32. Rafikova O., Salah E.M., Tofovic S.P. Renal and metabolic effects of tempol in obese ZSF1 rats-distinct role for superoxide and hydrogen peroxide in diabetic renal injury. Metabolism 2008, 57:1434-1444.
33. Reed T., Kirkwood S.C., DeCarli C., Swan G.E., Miller B.L., Wolf P.A., et al. Relationship of family history scores for stroke and hypertension to quantitative measures of white-matter hyperintensities and stroke volume in elderly males. Neuroepidemiology 2000, 19:76-86.
34. Ryan C.M., Williams T.M. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J. Clin. Exp. Neuropsychol. 1993, 15:685-700.
35. Ryan C.M., Williams T.M., Finegold D.N., Orchard T.J. Cognitive dysfunction in adults with Type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 1993, 36:329-334.
36. Sabbatini M., Catalani A., Consoli C., Marletta N., Tomassoni D., Avola R. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?. Mech. Ageing Dev. 2002, 123:547-559.
37. Schmidt R., Fazekas F., Offenbacher H., Dusek T., Zach E., Reinhart B., Grieshofer P., Freidl W., Eber B., Schumacher M. Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 1993, 43:2490-2494.
38. Schmidt R., Launer L.J., Nilsson L.G., Pajak A., Sans S., Berger K., Breteler M.M., de Ridder M., Dufouil C., Fuhrer R., Giampaoli S., Hofman A. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004, 53:687-692. CASCADE Consortium.
39. Schoenle E.J., Schoenle D., Molinari L., Largo R.H. Impaired intellectual development in children with Type 1 diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 2002, 45:108-114.
40. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Küstermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., Brüning J.C. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3100-3105.
41. Selkoe D.J. Clearing the brain's amyloid cobweb. Neuron 2001, 32:177-180.
42. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 2008, 11:309-317.
43. Terry A.V., Hernandez C.M., Buccafusco J.J., Gattu M. Deficits in spatial learning and nicotinic-acetylcholine receptors in older, spontaneously hypertensive rats. Neuroscience 2000, 101:357-368.
44. Toth C., Schmidt A.M., Tuor U.I., Francis G., Foniok T., Brussee V., Kaur J., Yan S.F., Martinez J.A., Barber P.A., Buchan A., Zochodne D.W. Diabetes, leukoencephalopathy and RAGE. Neurobiol. Dis. 2006, 23:445-461.
45. van der Heide L.P., Kamal A., Artola A., Gispen W.H., Ramakers G.M. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J. Neurochem. 2005, 94:1158-1166.
46. Vermeer S.E., Hollander M., van Dijk E.J., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003, 34:1126-1129.
47. Yang C., DeVisser A., Martinez J.A., Poliakov I., Rosales-Hernandez A., Ayer A., Garven A., Zaver S., Rincon N., Xu K., Tuor U.I., Schmidt A.M., Toth C. Differential impact of diabetes and hypertension in the brain: adverse effects in white matter. Neurobiol. Dis. 2011, 42(3):446-458.